- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Insulet Corporation (PODD)
Insulet Corporation stock price live, this page displays NASDAQ PODD stock exchange data. View the PODD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Insulet Corporation real time stock price chart below.
What Is the Insulet Corporation Stock Price Today?
The Insulet Corporation stock price today is 284.91.
What Is the Stock Symbol for Insulet Corporation?
The stock symbol for Insulet Corporation is ""PODD.""
What Stock Exchange Does Insulet Corporation Trade On?
Insulet Corporation is listed and trades on the NASDAQ stock exchange.
Is Insulet Corporation a Good Stock to Buy?
Determining whether Insulet Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PODD quote. (ISIN: US45784P1012)
What Is the Insulet Corporation Stock Price Today?
The Insulet Corporation stock price today is 284.91.
What Is the Stock Symbol for Insulet Corporation?
The stock symbol for Insulet Corporation is ""PODD.""
What Stock Exchange Does Insulet Corporation Trade On?
Insulet Corporation is listed and trades on the NASDAQ stock exchange.
Is Insulet Corporation a Good Stock to Buy?
Determining whether Insulet Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PODD quote. (ISIN: US45784P1012)
284.91
-3.49(-1.21%)
Closed·
Pre Market
284.20-0.71(-0.25%)
·
Fair Value
An estimate of a Insulet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
282.75
287.40
52 wk Range
173.00
329.33
PODD Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
PODD is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Insulet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
282.75287.40
52 wk Range
173.00329.33
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PODD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Insulet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
340.13
Upside
+19.38%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Insulet Corporation Company Profile
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Insulet Corporation SWOT Analysis
Diabetes Tech Leade | Insulet's Omnipod system drives 30% worldwide growth, with Q1 2025 sales exceeding expectations and prompting upward revision of revenue guidance |
Market Expansion | Explore Insulet's strategic focus on the Type 2 diabetes market, representing over 30% of new customers and offering significant growth potential |
Global Reach | Delve into Insulet's international success, with recent launches in Canada and Switzerland contributing to robust growth beyond U.S. borders |
Analyst Optimism | Learn about analyst price targets ranging from $266 to $360, reflecting confidence in Insulet's market position and growth prospects |
Insulet Corporation Earnings Call Summary for Q1/2025
- Q1 2025 EPS of $1.02 beat forecast by 29%; revenue grew 30% YoY to $569M, surpassing expectations
- Gross margin improved to 71.9%, up 240 bps; stock surged 8.95% after-hours on strong results
- FY2025 outlook: 20-23% Omnipod revenue growth; 100+ bps annual operating margin improvement targeted
- CEO highlights leadership in automated insulin delivery; potential for growth in Type 2 diabetes market emphasized
- Risks include supply chain disruptions, market saturation, and emerging competition in diabetes care
Last Updated: 08/05/2025, 22:34
Read Full TranscriptCompare PODD to Peers and Sector
Metrics to compare | PODD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPODDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 49.9x | −3.8x | −0.5x | |
PEG Ratio | 0.74 | −0.28 | 0.00 | |
Price/Book | 15.1x | 2.8x | 2.6x | |
Price / LTM Sales | 9.1x | 3.7x | 3.3x | |
Upside (Analyst Target) | 22.8% | 52.1% | 45.1% | |
Fair Value Upside | Unlock | 6.2% | 7.4% | Unlock |
Analyst Ratings
21 Buy
3 Hold
0 Sell
Ratings:
24 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 340.13
(+19.38% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
1.02 / 0.79
Revenue / Forecast
569.00M / 543.22M
People Also Watch
FAQ
What Stock Exchange Does Insulet Trade On?
Insulet is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Insulet?
The stock symbol for Insulet is "PODD."
What Is the Insulet Market Cap?
As of today, Insulet market cap is 20.05B.
What Is Insulet's Earnings Per Share (TTM)?
The Insulet EPS (TTM) is 5.73.
When Is the Next Insulet Earnings Date?
Insulet will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is PODD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Insulet Stock Split?
Insulet has split 0 times.
How Many Employees Does Insulet Have?
Insulet has 3900 employees.
What is the current trading status of Insulet (PODD)?
As of 04 Aug 2025, Insulet (PODD) is trading at a price of 284.91, with a previous close of 284.91. The stock has fluctuated within a day range of 282.75 to 287.40, while its 52-week range spans from 173.00 to 329.33.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.